A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Henry Fehrenbach et al.|Kidney International|2020Cited by 151
An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in ChildrenSebastian Loos, Markus J. Kemper, Thurid Ahlenstiel et al.|Clinical Infectious Diseases|2012Cited by 149
Phenotypic Spectrum of Children with Nephronophthisis and Related CiliopathiesJens König, Birgitta Kranz, Sabine König et al.|Clinical Journal of the American Society of Nephrology|2017Cited by 107